Skip to main content

8 Result(s)

within Carlos Barcia Remove this filter Neurosciences Remove this filter

and

  1. No Access

    Living Reference Work Entry In depth

    MPTP: Advances from an Evergreen Neurotoxin

    Since its discovery in 1976, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models in rodents and nonhuman primates have continuously renewed to keep up with progresses of Parkinson’s disease (PD) researc...

    Anna R. Carta, Augusta Pisanu, Maria Francesca Palmas… in Handbook of Neurotoxicity

  2. No Access

    Reference Work Entry In depth

    MPTP: Advances from an Evergreen Neurotoxin

    Since its discovery in 1976, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models in rodents and nonhuman primates have continuously renewed to keep up with progresses of Parkinson’s disease (PD) researc...

    Anna R. Carta, Augusta Pisanu, Maria Francesca Palmas… in Handbook of Neurotoxicity (2022)

  3. Article

    Open Access

    Three-dimensional vascular microenvironment landscape in human glioblastoma

    The cellular complexity of glioblastoma microenvironments is still poorly understood. In-depth, cell-resolution tissue analyses of human material are rare but highly necessary to understand the biology of this...

    George P. Cribaro, Elena Saavedra-López… in Acta Neuropathologica Communications (2021)

    Download PDF (16277 KB) View Article

  4. No Access

    Reference Work Entry In depth

    MPTP: Advances from an Evergreen Neurotoxin

    Since its discovery in 1976, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models in rodents and nonhuman primates have continuously renewed to keep up with progresses of Parkinson’s disease (PD) researc...

    Anna R. Carta, Augusta Pisanu, Carlos Barcia, M. T. Herrero in Handbook of Neurotoxicity (2014)

  5. No Access

    Chapter and Conference Paper

    Modulatory Role of NK1 Receptors in the Basal Ganglia. Studies in NK1-/- Mice

    Laura Turpín, Jorge Boronat, Carlos Barcia, María Gómez… in The Basal Ganglia VIII (2005)

  6. No Access

    Article

    Parkinson's disease and inflammatory changes

    In 1988 McGeer and colleagues (Neurology 38, 1285–91) observed an activation of the microglia in substantia nigrapars compacta (SNpc) and striatum of brains from patients with Parkinson's disease. In the years th...

    Carlos Barcia, Andrés Fernández Barreiro, Máximo Poza… in Neurotoxicity Research (2003)

  7. No Access

    Article

    Functional anatomy of thalamus and basal ganglia

    Thalamus.The human thalamus is a nuclear complex located in the diencephalon and comprising of four parts (the hypothalamus, the epythalamus, the ventral thalamus, and the dorsal thalamus). The t...

    María-Trinidad Herrero, Carlos Barcia, Juana Navarro in Child’s Nervous System (2002)

  8. No Access

    Chapter

    Blood Vessels And Neurodegeneration In Parkinson’s Disease

    Parkinson’s disease (PD) is characterised by a differential vulnerability of dopaminergic neurons in the mesencephalon. The loss is severe in the substantia nigra pars compacta (SNpc) (85-90%), intermediate in th...

    Carlos Barcia, Angel Sánchez-Bahillo, Victor Bautista-Hernández… in The Basal Ganglia VII (2002)